Related Experiment Videos
[Complement activation by C-reactive protein in various inflammatory diseases (in vitro)]
P Vaith1, M Schlayer, S Engelter
1Abteilung für Rheumatologie und Klinische Immunologie, Universitätsklinik Freiburg.
Immunitat Und Infektion
|February 1, 1992
Summary
C-reactive protein (CRP) complement activation testing showed unexpected negative results in rheumatoid arthritis and bacterial endocarditis patients, despite elevated CRP levels. This challenges current diagnostic assumptions for these inflammatory conditions.
Area of Science:
- Immunology and Rheumatology
- Complement System Activation
- Inflammatory Biomarkers
Context:
- C-reactive protein (CRP) is a key inflammatory marker.
- Complement activation is often assessed via C3-IFT on rat kidney sections.
- Polymyalgia rheumatica typically shows positive C3-IFT results.
Purpose:
- To investigate C-reactive protein (CRP)-mediated complement activation using indirect immunofluorescence (C3-IFT).
- To evaluate C3-IFT results in patients with rheumatoid arthritis and bacterial endocarditis.
- To explore the diagnostic and pathophysiological implications of unexpected C3-IFT findings.
Summary:
- Unexpectedly negative C3-IFT results were observed in 5/18 rheumatoid arthritis patients and 11/14 bacterial endocarditis patients.
- These negative results occurred despite elevated CRP levels and normal hemolytic complement in the tested sera.
- Findings contrast with typically positive C3-IFT results seen in polymyalgia rheumatica.
Impact:
- Highlights potential limitations of using C3-IFT for assessing CRP-mediated complement activation in certain inflammatory diseases.
- Suggests a need for re-evaluation of diagnostic criteria and understanding of complement pathways in rheumatoid arthritis and bacterial endocarditis.
- Opens avenues for further research into differential diagnostic and pathophysiological mechanisms.